500.49
+4.66
+(0.94%)
At close: April 15 at 4:00:01 PM EDT
495.29
-5.20
(-1.04%)
Pre-Market: 8:00:04 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 247,348 | 20 |
| Sales | 57,358 | 24 |
| Net Shares Purchased (Sold) | 189,990 | 44 |
| Total Insider Shares Held | 341.53k | -- |
| % Net Shares Purchased (Sold) | 124.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALTSHULER DAVID Officer | Sale at price 510.00 per share. | Direct | 1,647,810 | Mar 13, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Sale at price 500.00 per share. | Direct | 1,649,000 | Mar 10, 2025 |
| ALTSHULER DAVID Officer | Sale at price 500.00 per share. | Direct | 1,615,500 | Mar 10, 2025 |
| TATSIS OURANIA Officer | Sale at price 499.99 per share. | Direct | 1,620,968 | Mar 10, 2025 |
| TATSIS OURANIA Officer | Sale at price 485.49 per share. | Direct | 1,970,118 | Mar 4, 2025 |
| ALTSHULER DAVID Officer | Sale at price 490.00 per share. | Direct | 1,583,190 | Mar 3, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.00 per share. | Direct | 610,560 | Feb 27, 2025 |
| TATSIS OURANIA Officer | Sale at price 475.34 per share. | Direct | 251,930 | Feb 27, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Sale at price 475.34 per share. | Direct | 1,259,651 | Feb 27, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.95 per share. | Direct | 407,846 | Feb 25, 2025 |
| TATSIS OURANIA Officer | Sale at price 480.95 per share. | Direct | 170,256 | Feb 25, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 480.95 per share. | Direct | 425,160 | Feb 25, 2025 |
| ATKINSON EDWARD MORROW III Officer | Sale at price 480.95 per share. | Direct | 849,839 | Feb 25, 2025 |
| ALTSHULER DAVID Officer | Sale at price 480.00 per share. | Direct | 533,280 | Feb 20, 2025 |
| BILLER JONATHAN PRIM Officer | Sale at price 455.06 per share. | Direct | 754,034 | Feb 18, 2025 |
| TATSIS OURANIA Officer | Sale at price 455.06 per share. | Direct | 111,035 | Feb 18, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 455.06 per share. | Direct | 305,345 | Feb 18, 2025 |
| LEIDEN JEFFREY M Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| SACHDEV AMIT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ALTSHULER DAVID Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| BILLER JONATHAN PRIM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| TATSIS OURANIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| BOZIC CARMEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| AMBROSE KRISTEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| BILLER JONATHAN PRIM Officer | Sale at price 459.87 per share. | Direct | 1,578,734 | Feb 11, 2025 |
| TATSIS OURANIA Officer | Sale at price 459.83 per share. | Direct | 142,547 | Feb 11, 2025 |
| AMBROSE KRISTEN Officer | Sale at price 459.83 per share. | Direct | 632,726 | Feb 11, 2025 |
| ATKINSON EDWARD MORROW III Chief Technology Officer | Sale at price 459.83 per share. | Direct | 803,323 | Feb 11, 2025 |
| LEIDEN JEFFREY M Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| WAGNER CHARLES F JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| SACHDEV AMIT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ALTSHULER DAVID Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ARBUCKLE STUART A Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| KEWALRAMANI RESHMA Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| BOZIC CARMEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| AMBROSE KRISTEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ATKINSON EDWARD MORROW III Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| ALTSHULER DAVID Officer | Sale at price 478.56 per share. | Direct | 7,178 | Nov 15, 2024 |
| WAGNER CHARLES F JR Chief Financial Officer | Sale at price 518.27 per share. | Direct | 1,554,810 | Nov 11, 2024 |
| KEWALRAMANI RESHMA Chief Executive Officer | Sale at price 515.00 per share. | Direct | 7,826,970 | Nov 8, 2024 |
| BILLER JONATHAN PRIM Officer | Sale at price 461.66 per share. | Direct | 461,198 | Oct 2, 2024 |
| LEIDEN JEFFREY M Officer and Director | Sale at price 499.00 per share. | Direct | 1,888,216 | Aug 30, 2024 |
| BHATIA SANGEETA N Director | Sale at price 500.00 per share. | Direct | 323,000 | Aug 30, 2024 |
| BHATIA SANGEETA N Director | Conversion of Exercise of derivative security at price 152.74 per share. | Direct | 98,670 | Aug 30, 2024 |
| BHATIA SANGEETA N Director | Sale at price 466.29 per share. | Direct | 602,447 | Aug 8, 2024 |
| BHATIA SANGEETA N Director | Conversion of Exercise of derivative security at price 152.74 per share. | Direct | 197,340 | Aug 8, 2024 |
Related Tickers
CRSP CRISPR Therapeutics AG
38.95
+0.36%
REGN Regeneron Pharmaceuticals, Inc.
557.91
-2.30%
VKTX Viking Therapeutics, Inc.
23.11
-5.94%
ALNY Alnylam Pharmaceuticals, Inc.
230.93
-3.78%
SMMT Summit Therapeutics Inc.
24.62
-5.78%
SRPT Sarepta Therapeutics, Inc.
54.42
-0.38%
MRNA Moderna, Inc.
26.24
-2.09%
ARGX argenx SE
605.38
-0.17%
NTLA Intellia Therapeutics, Inc.
7.36
-1.87%
RXRX Recursion Pharmaceuticals, Inc.
5.64
+2.36%